Spero Therapeutics, Inc. Business Finance Contracts & Agreements
30 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Equity Distribution Agreements (5)
- Exchange Agreements (1)
- Financing Agreements (1)
- Investment Agreements (1)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Security Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (4)
- Warrant Agreements (2)
Recent Contracts
Category
Company
Industry
Jur.
Filed
Spero Therapeutics, Inc.
DE
2025
Spero Therapeutics, Inc.
DE
2024
Description of Spero Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Spero Therapeutics, Inc.
DE
2022
Spero Therapeutics, Inc.
MA
2021
Spero Therapeutics, Inc.
NY
2021
Spero Therapeutics, Inc.
MA
2020
Spero Therapeutics, Inc.
DE
2020
Spero Therapeutics, Inc.
NY
2018
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc. Amended and Restated 2017 Stock Incentive Plan (as Amended October 5, 2023)
Spero Therapeutics, Inc.
DE
2023
Spero Therapeutics, Inc.
DE
2022
Spero Therapeutics, Inc.
NY
2021
Spero Therapeutics, Inc.
NY
2021
Spero Therapeutics, Inc. Amended and Restated 2017 Stock Incentive Plan (as Amended August 17, 2021)
Spero Therapeutics, Inc.
DE
2021
Spero Therapeutics, Inc.
DE
2021
Spero Therapeutics, Inc.
NY
2020
Description of Spero Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Spero Therapeutics, Inc.
DE
2020
Securities Purchase Agreement between Spero Therapeutics, Inc. and Novo Holdings A/S (June 12, 2019)
Spero Therapeutics, Inc.
NY
2019
Spero Therapeutics, Inc.
NY
2019
Spero Therapeutics, Inc.
2018
Spero Therapeutics, Inc.
NY
2018
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
NY
2017
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
MA
2017
Spero Therapeutics, Inc.
DE
2017
Spero Therapeutics, Inc.
2017